Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) EBITDA
Veeva Systems Inc.'s EBITDA for fiscal 2026 was $961.1M, up 33.1% from $721.9M in fiscal 2025. Over the twelve months to 31 July 2026 it was $1.1B. Over the past ten years it has ranged from $76.1M (fiscal 2015) to $961.1M (fiscal 2026) — the current reading is the highest in ten years. Veeva Systems Inc. ranks 1st of 50 Health Information Services companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $961.1M | 33.13% |
| FY2025 | $721.9M | 59.14% |
| FY2024 | $453.6M | (10.47%) |
| FY2023 | $506.7M | (10.36%) |
| FY2022 | $565.3M | 31.13% |
| FY2021 | $431.1M | 33.32% |
| FY2020 | $323.3M | 27.86% |
| FY2019 | $252.9M | 32.93% |
| FY2018 | $190.2M | 26.36% |
| FY2017 | $150.6M | 67.55% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jul 2026 | $289.7M | 0.67% |
| Apr 2026 | $287.8M | 12.71% |
| Jan 2026 | $255.4M | 1.15% |
| Oct 2025 | $252.4M | 21.27% |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| VEEV Veeva Systems Inc. | $1.1B |
| BTSG BrightSpring Health Services, Inc. compare | $620.1M |
| HQY HealthEquity, Inc. compare | $510.0M |
| WAY Waystar Holding Corp. compare | $435.1M |
| DOCS Doximity, Inc. compare | $218.1M |
| HNGE Hinge Health Inc. compare | $161.2M |
| TXG 10x Genomics compare | −$40.4M |
| HTFL Heartflow, Inc. compare | −$72.7M |
| TEM Tempus AI, Inc. compare | −$170.5M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement